BUY Divi's Laboratories Limited — Kavita Jain, Arihant Capital Markets
Divi's Laboratories share price target & all analyst calls
byKavita Jain, Arihant Capital MarketsHorizon: BTST6 Oct 2026, 3:08 pm ISTvia CNBC Awaaz.
Entry₹9,520.5Inferred
Stop loss₹9,350-1.79% risk
At expiry₹9,5967 Oct 2026, 3:05 pm
Expired+0.79%
Follow Kavita Jain for new calls(21% target hit, 24 closed calls)Get alertsWatch DIVISLAB for new buy/sell callsGet alertsSee 4 active BTST picks this session
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
0 supporting1 neutral0 opposing
Supports the BUY call (0)
Nothing found in this tip’s window yet.
Neutral / worth noting (1)
Weighs against the BUY call (0)
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Divi's Laboratories
- BUY — Chandan Taparia, Motilal Oswal24 Sept 2026 · ~2 weeks · target ₹10,000 · SL hit
- BUY — Manas Jaiswal23 Sept 2026 · ~2 weeks · target ₹9,900 · SL hit
- BUY — Prakash Gaba18 Sept 2026 · Same day · target ₹9,500 · Expired
- BUY — Manas Jaiswal17 Sept 2026 · ~2 weeks · target ₹9,600 · Target hit
- BUY — Kunal Bothra16 Sept 2026 · Same day · target ₹9,320 · SL hit
More from Kavita Jain, Arihant Capital Markets
- SELL Container Corporation of India8 Oct 2026 · Same day · target ₹430 · Expired
- BUY R R Kabel6 Oct 2026 · ~2 weeks · target ₹2,850 · SL hit
- BUY Zydus Lifesciences6 Oct 2026 · ~2 weeks · target ₹1,175 · SL hit
- BUY Delhivery29 Sept 2026 · ~2 weeks · target ₹425 · SL hit
- SELL Prestige Estates Projects29 Sept 2026 · ~2 weeks · target ₹1,415 · SL hit

